Press Releases
Scientific Posters & Publications
- Nonclinical Characterization of ICVB-1042, a Novel E2F-tumor Selective Oncolytic Virus with Potential to Treat Solid Tumors (SITC 2022)
- The Ad5/34 Chimeric Fiber of ICVB-1042 Binds Human CD46 for Efficient Tumor Cell Entry (SITC 2022)
- Evaluation of the anti-tumor activity of ICVB-1042, a novel E2F-tumor selective oncolytic virus, targeting tumor cells in an established human glioblastoma mouse model (SITC 2022)